Mr. Mowry, age 54, has served as President and Chief Executive Officer of Vyaire Medical since May 2016. From October 2015 to May 2016 he served as Executive Vice President and Chief Operating Officer and member of the board of directors of Wright Medical Group N.V. (Nasdaq:WMGI). Between September 2015 and November 2016 he was a member of the board of directors of EndoChoice Holdings, Inc. Prior to Wright Medical, Mr. Mowry served as President and Chief Executive Officer and member of the board of directors of Tornier N.V. from February 2013 until completing the merger with Wright Medical in October 2015 and as Chief Operating Officer of Tornier from 2011 to 2013. Prior to this, Mr. Mowry held executive leadership positions at Covidien, ev3, and Zimmer Spine. Mr. Mowry receive a B.S. in Engineering from the United States Military Academy at West Point.Further information regarding the Company's appointment of David H. Mowry to its board of directors is set forth in a Current Report on Form 8-K that was filed with the U.S. Securities and Exchange Commission (SEC) on February 14, 2017 and is available on both the SEC's website at www.sec.gov and the Company's website at www.alphatecspine.com. About Alphatec Spine Alphatec Spine, Inc., a wholly owned subsidiary of Alphatec Holdings, Inc., is a global medical device company that designs, develops and markets spinal fusion technology products and solutions for the treatment of spinal disorders associated with disease and degeneration, congenital deformities and trauma. The Company's mission is to improve lives by delivering advancements in spinal fusion technologies. The Company and its affiliates market products in the U.S. via a direct sales force and independent distributors. Additional information can be found at www.alphatecspine.com. Forward Looking Statements This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainty. Such statements are based on management's current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Alphatec Spine cautions investors that there can be no assurance that actual results or business conditions will not differ materially from those projected or suggested in such forward-looking statements as a result of various factors. Forward-looking statements include the Company's ability to build a high-growth U.S. spine company through innovation and value creation and the Company's ability to achieve its strategic goals. The words "believe," "will," "should," "expect," "intend," "estimate" and "anticipate," variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. Please refer to the risks detailed from time to time in Alphatec Spine's SEC reports, including its Annual Report Form 10-K, as well as other filings on Form 10-Q and periodic filings on Form 8-K. Alphatec Spine disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, unless required by law.
CONTACT: Investor/Media Contact:Christine ZedelmayerInvestor Relations Alphatec Spine, Inc.(760) email@example.com